Menu
Latest Information
July 22 2014

medwireNews: Some patients with metastatic renal cell carcinoma (mRCC) who are switched from a traditional sunitinib treatment schedule to an alternative schedule fare better on survival measures and suffer fewer adverse events, a Japanese study has found.

April 23, 2014
Reduced risk of progression of localized RCC observed in patients on statins. Use of statins is associated with a reduced risk of progression of localized renal cell carcinoma, according to research published in The Journal of Urology.
April 15, 2014
In a study of 90 patients with a median age of 69.5 years who underwent RFA for biopsy-proven small RCC tumors, investigators observed local tumor recurrence in only 1 patient after a median follow-up of 55 months.
Print this page Tell A Friend Add to Favorites

Dr. Anil Kapoor

Dr. Anil Kapoor

Professor

Urology

Director of Research, Division of Urology
Program Director, Urology Residency Program
Surgical Director, Renal Transplantation, St. Joseph’s Hospital
Chair, Genito-Urinary Oncology Program, Juravinski Cancer Centre

Office:

St. Josephs Healthcare
Institute of Urology
50 Charlton Ave E, Room G344
Hamilton, ON L8N 4A6

Support Staff:
Cheryl Boult (Administrative Assistant)
Phone: (905) 522-1155 ext. 33218
Email: boultc@mcmaster.ca

Liz Sidorkewicz (Research Coordinator)
Phone: (905) 522-1155 ext. 35214
Email: sidorke@mcmaster.ca

Clinical Interest

Main area of research focus is kidney disease, including renal cell carcinoma and renal transplantation. Recent investigations include cell signaling pathways involved in localized and metastatic renal cell cancer, examining the role of pTEN, cdk11, and the mTOR pathway; and therapeutic targeting of the mTOR pathway using the mTOR inhibitors, in metastatic renal cell cancer. In the transplant field, examination of the role of mTOR inhibitors in allograft function and malignancy including the cell signaling pathways. Other areas of research interest include the role of minimally invasive surgery in the treatment of urologic malignancies, including robotic platforms.

Education

B.Sc., Dalhousie University
B.Engr., McGill University
M.D., Dalhousie University
Urology Residency, University of Manitoba
F.R.C.S. (C)- Urology
Renal Transplant and Renovascular Surgery Fellowship, Cleveland Clinic Foundation (USA)

Awards and Professional Affiliations

St. Joseph’s Healthcare Medical Staff Education Award (2004)
Canadian Urological Association Foundation Scholar (2000-2001)
Young Investigator Travel Award, Transplantation Society Sixth Basic Sciences Symposium (1999)
Lower Fellowship Thesis Award, Honorable Mention, Cleveland Clinic Foundation (1999)
First Prize, Ohio Urological Society (OUS) Essay Contest, Annual Meeting (1999)
First Prize, American College of Surgeons (ACS) Annual Scientific Meeting (1995)
First Prize, Resident's Research Colloquium Competition, Department of Surgery, University of Manitoba (1995)
CSCI/MRC National Resident's Research Award, University of Manitoba (1995-1996)
Best Poster Presentation, American Urological Association Meeting, Las Vegas (1995)

Father Sean O’Sullivan Research Centre
American Society of Transplantation
Canadian Society of Transplantation
American Urological Association
Canadian Urological Association
Canadian Medical Association
Ontario Medical Association
Hamilton Academy of Medicine,
EndoUrological Society
Canadian Urology Research Consortium
Canadian Academy of Urological Surgeons
Canadian Urologic Oncology Group